Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Poseida Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 71 | 65 | −6 |
| Shares | 27.9M | 26.2M | −1.72M (−6.2%) |
| Value | $279.3M | $190.7M | −$88.6M (−31.7%) |
New holders (9)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Privium Fund Management (UK) Ltd | 48,470 | $353.0K | 0.38% |
| Altium Capital Management LP | 32,238 | $235.0K | 0.06% |
| SG Americas Securities, LLC | 21,323 | $155.0K | 0.00% |
| Martingale Asset Management L P | 15,615 | $114.0K | 0.00% |
| Renaissance Technologies LLC | 12,900 | $94.0K | 0.00% |
| Trexquant Investment LP | 12,442 | $91.0K | 0.01% |
| Forefront Analytics, LLC | 10,345 | $72.0K | 0.03% |
| Signaturefd, LLC | 98 | $1.00K | 0.00% |
| Berman Capital Advisors, LLC | 273 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Boxer Capital, LLC | 1,251,055 | $12.5M |
| Ikarian Capital, LLC | 85,837 | $861.0K |
| Balyasny Asset Management LLC | 80,202 | $804.0K |
| Pendal Group Limited | 48,561 | $487.0K |
| Parametric Portfolio Associates LLC | 36,961 | $370.0K |
| Ergoteles LLC | 28,300 | $284.0K |
| Citadel Advisors LLC | 20,710 | $208.0K |
| Manufacturers Life Insurance Company, The | 19,599 | $196.0K |
| Federated Hermes, Inc. | 16,656 | $167.0K |
| ExodusPoint Capital Management, LP | 15,200 | $152.0K |
| Boothbay Fund Management, LLC | 13,304 | $133.0K |
| Pinz Capital Management, LP | 11,200 | $112.0K |
| Jane Street Group, LLC | 10,110 | $101.0K |
| UBS Group AG | 2,000 | $20.0K |
| NEXT Financial Group, Inc | 300 | $3.00K |